1:34:42 PM PDT - Saturday, June 6th, 2020

Peer-reviewed data shows Gilead's drug helps COVID-19 recovery time  

By Editor - Fri May 22, 7:07 pm

  • Comments Off on Peer-reviewed data shows Gilead's drug helps COVID-19 recovery time

The trial, for which final results are still trickling in, showed that recovery time for patients given remdesivir was shortened by four days, or 31%, compared to placebo patients. The data detailed in the journal is similar to early data that the NIH released last month from the study, which began in February with 1,063 participants in 10 countries. Researchers now calculate that after 14 days of follow up, 7% of patients given remdesivir will have died, compared with 12% in the placebo group, but they said the difference in the death rate was not significant.

Visit link:

Peer-reviewed data shows Gilead's drug helps COVID-19 recovery time

  • Comments Off on Peer-reviewed data shows Gilead's drug helps COVID-19 recovery time

Leave a Reply

Comments are closed on this post.